EUVIMEDEUVIMED entdecken
Open Access

TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers

Suhair Lolas-Hamameh iD, Sari Lieberman, Alaa Sarahneh, Tom Walsh iD, Ming K Lee iD, Suleyman Gulsuner, Grace Rabie iD, Rachel Beeri iD, Amal Aburayyan iD, Jessica B Mandell iD, Hila Fridman iD, Galit Lazer-Derbeko und 6 weitere

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djae334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Suhair Lolas-Hamameh und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hereditary Research Laboratory, Bethlehem University, Bethlehem P1520468, Palestine. Hauptthemen laut MEDLINE: Breast Neoplasms, Genetic Predisposition to Disease, Tumor Suppressor Protein p53, Mutation, Missense. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Robin Chemers Neustein, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic TP53 germline variants cause young-onset breast cancer and other cancers of the Li-Fraumeni syndrome (LFS) spectrum, but the clinical consequences of partial-loss-of function TP53 variants are incompletely understood. In the consecutive cohort of Palestinian breast cancer patients of the Middle East Breast Cancer Study (MEBCS), breast cancer risk among TP53 p.R181C heterozygotes was 50% by age 50 years and 81% by age 80 years. In contrast, prevalence of pediatric cancers in the MEBCS was similar among first-degree relatives of TP53 p.R181C carriers (3/519 = 0.0058) and first-degree relatives of MEBCS patients with no pathogenic germline variant in any known breast cancer gene (7/1082 = 0.0065; odds ratio [OR] = 0.90, 95% confidence interval [CI] [0.23 to 3.49], Fisher P = .90 [2-tailed]). This result suggests that in families harboring this TP53 allele, genetic testing in children is unwarranted, and screening children for LFS tumors is unnecessary. More generally, some TP53 missense alleles can predispose to very high risk of breast cancer without pleiotropic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsGenetic Predisposition to DiseaseTumor Suppressor Protein p53Mutation, MissenseHumansFemaleMiddle AgedChildAdultLi-Fraumeni SyndromeAgedAllelesAged, 80 and overGerm-Line MutationMiddle EastAdolescentHeterozygote

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Hereditary Research Laboratory, Bethlehem University, Bethlehem P1520468, Palestine.
  • Fuld Family Institute of Medical Genetics, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
  • The Eisenberg R&D Authority, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
  • Department of Medicine (Medical Genetics), University of Washington, Seattle, WA 98195-7720, USA.
  • Department of Family Medicine, Clalit Health Services, Jerusalem 9548323, Israel.

ORCID-Profile: Suhair Lolas-Hamameh, Tom Walsh, Ming K Lee, Grace Rabie, Rachel Beeri, Amal Aburayyan, Jessica B Mandell, Hila Fridman, Amnon Lahad, Mary-Claire King, Ephrat Levy-Lahad, Moien N Kanaan

Förderung

  • NCI NIH HHS
  • Robin Chemers Neustein
  • American Cancer Society
  • NIGMS NIH HHS
  • Breast Cancer Research Foundation

Zitieren

APA

Lolas-Hamameh, S., Lieberman, S., Sarahneh, A., Walsh, T., Lee, M. K., Gulsuner, S., Rabie, G., Beeri, R., Aburayyan, A., Mandell, J. B., Fridman, H., Lazer-Derbeko, G., Klopstock, T., Freireich, O., Lahad, A., King, M. C., Levy-Lahad, E., & Kanaan, M. N. (2025). TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae334

Vancouver

Lolas-Hamameh S, Lieberman S, Sarahneh A, Walsh T, Lee MK, Gulsuner S, et al. TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae334

BibTeX
@article{LolasHamameh2025,
  author = {Lolas-Hamameh, Suhair and Lieberman, Sari and Sarahneh, Alaa and Walsh, Tom and Lee, Ming K and Gulsuner, Suleyman and Rabie, Grace and Beeri, Rachel and Aburayyan, Amal and Mandell, Jessica B and Fridman, Hila and Lazer-Derbeko, Galit and Klopstock, Tehila and Freireich, Orit and Lahad, Amnon and King, Mary-Claire and Levy-Lahad, Ephrat and Kanaan, Moien N},
  title = {TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djae334}
}
Kostenlos starten →